Clinical research - Press Releases

Date	Title	Company
31-Jan-2020	Clinerion and Datametrix partner to deliver Real World Evidence (RWE) insights from Real World Data (RWD) from Clinerion’s global hospital network.	Clinerion Ltd
31-Jan-2020	Reich Insurance launches innovative online Life Sciences insurance quote portal	Reich Insurance Group
30-Jan-2020	Cynbiose receives €1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases	Cynbiose
30-Jan-2020	European Medicines Agency Validates Kite's Marketing Authorisation Application for Company's Second CAR T Cell Therapy	Kite
30-Jan-2020	Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied StemCell’s Gene Editing Platform and Oncology Product Portfolio	ABCAM PLC
30-Jan-2020	REGULATORY ANNOUNCEMENT: Astellas Submits sNDA for Approval of Evrenzo® (roxadustat)	Astellas Pharma Inc.
30-Jan-2020	Sanofi: Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency	Sanofi
30-Jan-2020	FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis	Sanofi
30-Jan-2020	Autolus Announces Closing of Public Offering	Autolus Therapeutics plc
30-Jan-2020	Agilent Introduces New Cutting-Edge SureSelect DNA Kit	Agilent Technologies Inc.
30-Jan-2020	NuCana Announces First Patients Dosed in Both US and Europe in Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer	NuCana plc
30-Jan-2020	Akari Therapeutics Announces Preclinical Ophthalmic Data Showing Nomacopan Reduces Both Vascular Endothelial Growth Factor (VEGF) and Retinal Inflammation Supporting Nomacopan as a Potential Treatment Option for Back-of-the-Eye Diseases	Akari Therapeutics
30-Jan-2020	PharmaMar and Bionical Emas launch Expanded Access Program for lurbinectedin in relapsed Small Cell Lung Cancer in the U.S.	PharmaMar and Bionical Emas
30-Jan-2020	Bionetix, ProQinase, and Mercachemsyncom Announce a Joint Research Project from Target Identification to Clinical Study	Bionetix, ProQinase, and Mercachemsyncom
30-Jan-2020	Autolus' Chief Scientific Officer, Dr Martin Pulé, to give Keynote Lecture at the EHA-EBMT 2nd European CAR T Cell Meeting	Autolus Therapeutics plc
30-Jan-2020	Cresset joins 3D-NEONET consortium to help accelerate the development of novel therapeutics in cancer and ophthalmology	Cresset
29-Jan-2020	Caroline Benson and Colin Williams to Co-Chair the PM Society from 2020	The PM Society
29-Jan-2020	Most innovative cancer drugs facing delays in reaching patients	The Institute of Cancer Research
29-Jan-2020	Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis	Sanofi
29-Jan-2020	Kite, a Gilead Company, to present latest cell therapy research at the 2nd European CAR T Cell Meeting, Sitges, Spain	Gilead